SCHEMBL5573773

SCHEMBL5573773

CC(C)(C)OC(=O)N1CCC(NC(CNc2ccc(F)cc2)c2cccc(Cl)c2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
NPC1 O15118 1/20 0.49
MAPT P10636 1/20 0.49
MAPK1 P28482 1/20 0.49
HTT P42858 1/20 0.49
RAB9A P51151 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
STS P08842 2/20 0.49
TP53 P04637 1/20 0.47
GPR119 Q8TDV5 4/20 0.45
CCNT1 O60563 1/20 0.42
CYP3A4 P08684 2/20 0.42
CYP3A5 P20815 1/20 0.42
MMP13 P45452 1/20 0.42
LMNA P02545 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
DNMT3A Q9Y6K1 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5576034 0.89 ALDH1A1 (0.52) ALDH1A1NPC1MAPTMAPK1HTT
SCHEMBL4608693 0.87 STS (0.53) ALDH1A1NPC1MAPTMAPK1HTT
SCHEMBL4596528 0.87 ALDH1A1 (0.48) ALDH1A1NPC1MAPTMAPK1HTT
SCHEMBL5575926 0.85 STS (0.57) ALDH1A1NPC1MAPTMAPK1HTT
SCHEMBL5576735 0.83 STS (0.51) ALDH1A1NPC1MAPTMAPK1HTT
SCHEMBL5576153 0.81 STS (0.49) ALDH1A1NPC1MAPTMAPK1HTT
SCHEMBL4610832 0.81 STS (0.49) ALDH1A1NPC1MAPTMAPK1HTT
SCHEMBL4608779 0.81 STS (0.49) ALDH1A1NPC1MAPTMAPK1HTT
SCHEMBL28699743 0.78 STS (0.49) ALDH1A1NPC1MAPTMAPK1HTT
SCHEMBL8179659 0.78 ALDH1A1 (0.54) ALDH1A1NPC1MAPTMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070066624-A1 Chemokine receptor binding compounds ANORMED, INC. (CA) 2007-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066624-A1 Chemokine receptor binding compounds CCR5, CCR4, CCR1 ALDH1A1 3484/4885NPC1 473/4885MAPT 3432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.